Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
FEMALE
NCT06851130

Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women

Led by Swiss Federal Institute of Technology · Updated on 2025-05-20

120

Participants Needed

1

Research Sites

44 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Serum ferritin is a key indicator of body iron stores and is widely used in monitoring iron status. However, oral iron doses can acutely elevate SF levels, potentially biasing assessments of iron stores during supplementation. This study aims to investigate the extent and duration of the acute iron-induced effect on serum ferritin following the administration of a daily iron dose for two months.

CONDITIONS

Official Title

Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women

Who Can Participate

Age: 18Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Low iron stores with serum ferritin levels below 30 µg/L
  • No anemia with hemoglobin levels above 120 g/L
  • No inflammation with C-reactive protein levels below 5 mg/L
  • Age between 18 and 45 years old
  • Body weight less than 70 kg
  • Normal body mass index between 18.5 and 26.5 kg/m2
Not Eligible

You will not qualify if you...

  • Any chronic or acute disease
  • Taking mineral and vitamin supplements since screening and during the study
  • Blood transfusion, blood donation, or significant blood loss in the past 4 months
  • Pregnant or breastfeeding
  • Continuous or long-term use of medication during the study except contraceptives
  • Therapeutic iron infusion in the past 6 months
  • Known allergy or hypersensitivity to iron supplements
  • Planning to become pregnant during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Laboratory of Nutrition and Metabolic Epigenetics

Zurich, Canton of Zurich, Switzerland, 8092

Actively Recruiting

Loading map...

Research Team

N

Nicole Stoffel, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here